COMPANY PROFILE / #1758
Dash Bio
Boston, MAVenture Capital-Backed
OVERVIEW
Developer of a clinical bioanalysis platform intended to offer tech-enabled services for drug development. The company's platform adapts a technology-first approach to developing critical services across the drug development lifecycle, aiming to build new capabilities that leverage AI, robotics, and fully integrated software to deliver GLP-compliant services, enabling users to automate critical steps, reduce costs, and shorten time to market without compromising on quality.
已融资47.47
最新估值159.50
员工数41
成立年份2024
公司概况
- Companies
- Dash Bio
- Description
- Developer of a clinical bioanalysis platform intended to offer tech-enabled services for drug development. The company's platform adapts a technology-first approach to developing critical services across the drug development lifecycle, aiming to build new capabilities that leverage AI, robotics, and fully integrated software to deliver GLP-compliant services, enabling users to automate critical steps, reduce costs, and shorten time to market without compromising on quality.
- Website
- www.dash.bio
- HQ Location
- Boston, MA
- Year Founded
- 2024
- Keywords
- bioanalysis application, bioanalysis service, biotechnology company operator, drug development tech, drug development therapy, preclinical studies application
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 47.47
- First Financing Date
- 08-Oct-2024
- First Financing Size
- 6.47
- First Financing Valuation
- 25.00
- Last Financing Date
- 14-Jul-2026
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 30.00
- Last Financing Valuation
- 159.50
- Last Financing Status
- Completed
- Last Known Valuation
- 159.50
- Last Known Valuation Date
- 14-Jul-2026
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 176.36
- Valuation Estimate Growth Rate
- 10.57%
- Active Investors
- A-Level Capital, Companion-M, Cybernetix Ventures, Drive Capital, Freestyle Capital, Life Extension Ventures, Oak HC/FT, Sequoia Capital, Swift Ventures, The Aligned Fund
- # Active Investors
- 10
- Acquirers
- —
团队与联系人
- Employees
- 41
- Employee Growth %
- —
- Employee History
- 2026: 41
- Primary Contact
- David Johnson
- Primary Contact Title
- Co-Founder, Chief Executive Officer, President & Board Member
- Primary Contact Email
- dave@dash.bio
- Primary Contact Phone
- +1 (617) 249-4472
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 3.85x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 78
- Majestic Referring Domains
- 100
- SimilarWeb Unique Visitors
- 173
- SimilarWeb Unique Visitors Change
- -1
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 7%
- Success Probability Over Time – 3 Year
- 21%
- Success Probability Over Time – 5 Year
- 40%
记录来源：public.companies · 原始序号 #1758 · 所有字段均按数据库原值展示。